APLS
Price
$24.52
Change
+$0.37 (+1.53%)
Updated
Oct 17 closing price
Capitalization
3.1B
12 days until earnings call
ELVN
Price
$21.41
Change
-$0.34 (-1.56%)
Updated
Oct 17 closing price
Capitalization
1.27B
19 days until earnings call
Interact to see
Advertisement

APLS vs ELVN

Header iconAPLS vs ELVN Comparison
Open Charts APLS vs ELVNBanner chart's image
Apellis Pharmaceuticals
Price$24.52
Change+$0.37 (+1.53%)
Volume$1.65M
Capitalization3.1B
Enliven Therapeutics
Price$21.41
Change-$0.34 (-1.56%)
Volume$485.19K
Capitalization1.27B
APLS vs ELVN Comparison Chart in %
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. ELVN commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and ELVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (APLS: $24.52 vs. ELVN: $21.41)
Brand notoriety: APLS and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 76% vs. ELVN: 98%
Market capitalization -- APLS: $3.1B vs. ELVN: $1.27B
APLS [@Biotechnology] is valued at $3.1B. ELVN’s [@Biotechnology] market capitalization is $1.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 1 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 1 green, 4 red.
According to our system of comparison, ELVN is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 6 bullish TA indicator(s).

  • APLS’s TA Score: 5 bullish, 6 bearish.
  • ELVN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а -2.39% price change this week, while ELVN (@Biotechnology) price change was +2.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

APLS is expected to report earnings on Oct 30, 2025.

ELVN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($3.1B) has a higher market cap than ELVN($1.27B). ELVN YTD gains are higher at: -4.844 vs. APLS (-23.159). ELVN has higher annual earnings (EBITDA): -113.93M vs. APLS (-178.43M). ELVN has more cash in the bank: 491M vs. APLS (370M). ELVN has less debt than APLS: ELVN (580K) vs APLS (470M). APLS has higher revenues than ELVN: APLS (755M) vs ELVN (0).
APLSELVNAPLS / ELVN
Capitalization3.1B1.27B244%
EBITDA-178.43M-113.93M157%
Gain YTD-23.159-4.844478%
P/E RatioN/AN/A-
Revenue755M0-
Total Cash370M491M75%
Total Debt470M580K81,034%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSELVN
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOCX96.820.62
+0.64%
Rydex NASDAQ-100® Inv
GPTUX14.050.05
+0.38%
GuidePath® Tactical Allocation Svc
FEMKX48.80N/A
N/A
Fidelity Emerging Markets
FULVX11.92N/A
N/A
Fidelity U.S. Low Volatility Equity
SMSAX10.19-0.02
-0.20%
SEI Multi Strategy Alternatives F (SIMT)

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+1.53%
DNLI - APLS
49%
Loosely correlated
-0.36%
ARWR - APLS
43%
Loosely correlated
-5.54%
DAWN - APLS
43%
Loosely correlated
-3.61%
DYN - APLS
42%
Loosely correlated
-0.24%
ELVN - APLS
42%
Loosely correlated
-1.56%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with NUVL. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-1.56%
NUVL - ELVN
52%
Loosely correlated
+2.32%
SYRE - ELVN
52%
Loosely correlated
+1.03%
XNCR - ELVN
52%
Loosely correlated
-1.20%
DNLI - ELVN
51%
Loosely correlated
-0.36%
NRIX - ELVN
51%
Loosely correlated
-1.89%
More